Hyal regulatory update

Hyal Pharmaceutical Corp. (HYALF) HYALF (Toronto) submitted regulatory applications in the U.K., Ireland and Canada for marketing approval of its topical pain product HYAL-AT2101 ( Hyanalgese-D) to t...